Travaux scientifiques
Doç. Dr. İlkay Gültürk
52 publications. La source de l’information est indiquée à côté de chaque publication.
-
Bone Pain Is Associated with Short Radiographic Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15103968 PMID 42194929 Texte intégral en libre accèsSource : OpenAlex
-
Association between obesity and outcomes of first-line CDK4/6 inhibitor therapy in metastatic breast cancer: a multicenter real-world study
Scientific Reports, 2026
DOI 10.1038/s41598-026-58205-7 PMID 42304044 Texte intégral en libre accèsSource : OpenAlex
-
Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
Cancers, 2026
DOI 10.3390/cancers18142302 PMID 42512369 Texte intégral en libre accèsSource : ORCID
-
Kaposi Sarcoma Presenting as Hemophagocytic Lymphohistiocytosis Mimicking Infection and Lymphoma: A Diagnostic Challenge
Cureus, 2026
DOI 10.7759/cureus.105780 PMID 42037832 Texte intégral en libre accèsSource : OpenAlex
-
The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer
The Prostate, 2026
DOI 10.1002/pros.70185 PMID 42018584 Texte intégral en libre accèsSource : ORCID
-
Bone Pain Is Associated with Short Radiologic-Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer
2026
DOI 10.20944/preprints202604.1309.v1 Texte intégral en libre accèsSource : ORCID
-
Association of Pretreatment IronMLR and ANR With Pathological Response Following Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
SSRN Electronic Journal, 2026
DOI 10.2139/ssrn.7100220 Texte intégral en libre accèsSource : ORCID
-
Association of Pretreatment ANR and IronMLR With Pathological Response Following Neoadjuvant Chemotherapy in Breast Cancer
Breast Cancer Targets and Therapy, 2026
DOI 10.2147/bctt.s623894 PMID 42677318 Texte intégral en libre accèsSource : OpenAlex
-
A multi-center case-control study on osteoporosis risk in cancer patients receiving chemotherapy.
Journal of Clinical Oncology, 2025
DOI 10.1200/jco.2025.43.16_suppl.12033 Source : OpenAlex
-
A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy
Supportive Care in Cancer, 2025
DOI 10.1007/s00520-025-09973-x PMID 41225034 1 citation (Europe PMC) Source : OpenAlex
-
Very deep prostate-specific antigen decline is associated with longer rPFS in patients with metastatic castration-sensitive prostate cancer
Therapeutic Advances in Medical Oncology, 2025
DOI 10.1177/17588359251369037 PMID 40895017 Texte intégral en libre accèsSource : OpenAlex
-
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Scientific Reports, 2025
DOI 10.1038/s41598-025-96157-6 PMID 40188172 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors
Cancers, 2025
DOI 10.3390/cancers17040693 PMID 40002286 14 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors
Journal of Clinical Medicine, 2025
DOI 10.3390/jcm14041071 PMID 40004601 9 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Prognostic Importance of PTEN and P53 in Aggressive Luminal A Subtype Breast Cancers
European journal of breast health, 2025
DOI 10.4274/ejbh.galenos.2025.2025-2-12 PMID 40390381 2 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
The Relationship Between Changes in the Neutrophil-Lymphocyte Ratio (NLR) and Radiological Progression in Cervical Cancer
Istanbul Medical Journal, 2025
DOI 10.4274/imj.galenos.2025.59254 Texte intégral en libre accèsSource : OpenAlex
-
18F-FDG PET/CT Findings Mimicking Gallbladder Metastasis From a Rectal Adenocarcinoma: Rare Synchronous Gallbladder and Rectal Cancer
Clinical Nuclear Medicine, 2025
DOI 10.1097/rlu.0000000000005812 PMID 40029796 Source : OpenAlex
-
The impact of sarcopenia on adverse effects and survival in patients with metastatic hormone receptor-positive breast cancer treated with CDK4/6 inhibitors
Medicine, 2025
DOI 10.1097/md.0000000000043374 PMID 40660511 Texte intégral en libre accèsSource : ORCID
-
The Prognostic Value of the EASIX Score in Patients with Metastatic Pancreatic Cancer
Diagnostics, 2025
DOI 10.3390/diagnostics15141740 PMID 40722492 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
68Ga PSMA PET/CT and 18F FDG PET/CT Findings in Osteonecrosis of the Jaw Induced by Denosumab
Clinical Nuclear Medicine, 2025
DOI 10.1097/rlu.0000000000005751 PMID 40025661 5 citations (OpenAlex) Source : OpenAlex
-
The relationship between body mass index and survival in patients with renal cell carcinoma treated with nivolumab
Journal of Chemotherapy, 2025
DOI 10.1080/1120009x.2025.2469371 PMID 39988757 2 citations (OpenAlex) Source : OpenAlex
-
The Role of Magnetic Resonance Imaging in Predicting Pathological Complete Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Bagcilar Medical Bulletin, 2025
DOI 10.4274/bmb.galenos.2025.33042 Texte intégral en libre accèsSource : OpenAlex
-
Evaluación de la eficacia del tratamiento según los criterios RECIP 1.0 en el cáncer de próstata sensible a la castración
Actas Urológicas Españolas, 2025
DOI 10.1016/j.acuro.2025.501837 Source : OpenAlex
-
Evaluation of treatment efficacy according to RECIP 1.0 criteria in castration-sensitive prostate cancer
Actas Urológicas Españolas (English Edition), 2025
DOI 10.1016/j.acuroe.2025.501837 PMID 40939837 Source : OpenAlex
-
2407P Elevated SUVmax on gallium-68-PSMA-11 PET (PSMA-PET) is associated with shorter radiographic progression-free survival (rPFS) in patients with metastatic castration-sensitive prostate cancer (mCSPC)
Annals of Oncology, 2025
DOI 10.1016/j.annonc.2025.08.3023 Texte intégral en libre accèsSource : OpenAlex
-
Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients
Istanbul Medical Journal, 2024
DOI 10.4274/imj.galenos.2024.96266 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function
Actas Urológicas Españolas (English Edition), 2024
DOI 10.1016/j.acuroe.2024.04.002 PMID 38570033 Source : OpenAlex
-
The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study
Breast Cancer Research and Treatment, 2024
DOI 10.1007/s10549-024-07291-0 PMID 38526689 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4–6 inhibitors?
The Breast, 2024
DOI 10.1016/j.breast.2024.103820 PMID 39405594 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes
Cancers, 2024
DOI 10.3390/cancers16223880 PMID 39594835 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
Scientific Reports, 2024
DOI 10.1038/s41598-024-75293-5 PMID 39384975 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer
Journal of College of Physicians And Surgeons Pakistan, 2024
DOI 10.29271/jcpsp.2024.01.37 PMID 38185958 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Assessment of Oral Capecitabine in Elderly Patients with Stage 2 Colon Cancer: Toxicity, Tolerability, and Survival Outcomes
Istanbul Medical Journal, 2024
DOI 10.4274/imj.galenos.2024.64606 Texte intégral en libre accèsSource : OpenAlex
-
Comparison of Coronary Artery Calcium Score and Serum Calcium, Phosphorus, and Gamma-Glutamyl Transferase Levels in Patients with Coronary Artery Imaging by Multi-Sectional Computed Tomography with Chronic Ischemic Heart Disease Prediagnosis
Istanbul Medical Journal, 2024
DOI 10.4274/imj.galenos.2024.14602 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID
-
Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy
Journal of Oncology Pharmacy Practice, 2024
DOI 10.1177/10781552231221230 PMID 38111303 Source : ORCID
-
Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes
2024
DOI 10.20944/preprints202410.2285.v1 Texte intégral en libre accèsSource : ORCID
-
Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer
Asia-Pacific Journal of Clinical Oncology, 2024
DOI 10.1111/ajco.14065 PMID 38572819 2 citations (OpenAlex) Source : OpenAlex
-
Seguridad y eficacia del nivolumab para el tratamiento de pacientes con carcinoma de células renales metastásico e insuficiencia renal
Actas Urológicas Españolas, 2024
DOI 10.1016/j.acuro.2024.01.014 Source : OpenAlex
-
Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?
Supportive Care in Cancer, 2023
DOI 10.1007/s00520-023-07791-7 PMID 37162602 4 citations (Europe PMC) Source : ORCID
-
Naples prognostic score may predict overall survival in metastatic pancreatic cancer
Journal of Cancer Research and Therapeutics, 2023
DOI 10.4103/jcrt.jcrt_1392_22 PMID 38554329 12 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Naples Score May Predict Overall Survival in Metastatic Gastric Cancer and is Superior to CONUT
Acta Oncologica Turcica, 2023
DOI 10.5505/aot.2023.80269 Texte intégral en libre accèsSource : OpenAlex
-
Partial Atrophy of The Pancreas in Endoscopic Ultrasonography may be a Sign of Pancreatic Cancer
Istanbul Medical Journal, 2023
DOI 10.4274/imj.galenos.2023.52386 Texte intégral en libre accèsSource : ORCID
-
Temel Onkoloji
Akademisyen Kitabevi eBooks, 2022
DOI 10.37609/akya.1765 Source : OpenAlex
-
Nivolumab induced hypophysitis in an advanced RCC patient
Journal of Oncology Pharmacy Practice, 2022
DOI 10.1177/10781552211072212 PMID 35006033 3 citations (OpenAlex) Source : OpenAlex
-
With metastatic colorectal cancer: A single center experience use of monoclonal antibodies (Bevacizumab, Cetuximab, and Panitumumab) in patients
Journal of Experimental and Clinical Medicine, 2022
DOI 10.52142/omujecm.39.4.34 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Lutetium-Associated Myopathy: A Case Report
American Journal of Therapeutics, 2022
DOI 10.1097/mjt.0000000000001491 PMID 35383588 1 citation (OpenAlex) Source : OpenAlex
-
Time to Castration Resistance as a Predictor of Response to Docetaxel in Metastatic Castration Resistance in Prostate Cancer
Istanbul Medical Journal, 2022
DOI 10.4274/imj.galenos.2022.56804 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Prosnostic Significance of Prognostic Nutrition Index in Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
Namık Kemal Tıp Dergisi, 2022
DOI 10.4274/nkmj.galenos.2022.80764 Texte intégral en libre accèsSource : OpenAlex
-
Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders
The Turkish Journal of Gastroenterology, 2022
DOI 10.5152/tjg.2022.20844 PMID 35678799 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study
Melanoma Research, 2021
DOI 10.1097/cmr.0000000000000744 PMID 34039945 16 citations (Europe PMC) Source : OpenAlex